We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+30.27%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$116B
AUM Growth
+$12.9B
Cap. Flow
-$8.24B
Cap. Flow %
-7.11%
Top 10 Hldgs %
14.35%
Holding
3,987
New
584
Increased
1,418
Reduced
1,366
Closed
596

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$806M
2
ABBV icon
AbbVie
ABBV
+$481M
3
TMUS icon
T-Mobile US
TMUS
+$464M
4
KR icon
Kroger
KR
+$430M
5
BIDU icon
Baidu
BIDU
+$423M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.35B
2
AGN
Allergan plc
AGN
+$1.26B
3
S
Sprint Corporation
S
+$675M
4
AMGN icon
Amgen
AMGN
+$488M
5
HUM icon
Humana
HUM
+$450M

Sector Composition

Rank Sector Weight
1 Healthcare 23.45%
2 Technology 16.09%
3 Consumer Staples 10.57%
4 Consumer Discretionary 9.95%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USWS
3376
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$17K ﹤0.01%
1,615
-4,319
-73% -$42.9K
IHT
3377
InnSuites Hospitality Trust
IHT
$15.1M
$16K ﹤0.01%
16,600
+6,400
+63% +$5.9K
CSCI
3378
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$14K ﹤0.01%
181
TUSK icon
3379
Mammoth Energy Services
TUSK
$154M
$12K ﹤0.01%
+10,367
New +$12K
DLPN icon
3380
Dolphin Entertainment
DLPN
$15.9M
$11K ﹤0.01%
+1,240
New +$8.18K
PED icon
3381
PEDEVCO
PED
$160M
$9K ﹤0.01%
+570
New +$9.87K
DMK
3382
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9K ﹤0.01%
+244
New +$8.35K
NCSM icon
3383
NCS Multistage Holdings
NCSM
$132M
$7K ﹤0.01%
+618
New +$7.11K
VTGN icon
3384
VistaGen Therapeutics
VTGN
$11.8M
$6K ﹤0.01%
+398
New +$5.44K
ZN
3385
DELISTED
Zion Oil & Gas, Inc.
ZN
$3K ﹤0.01%
+11,726
New +$3.17K
A icon
3386
Agilent Technologies
A
$42.2B
-441,963
Closed -$31.7M
AAP icon
3387
Advance Auto Parts
AAP
$3.46B
-51,800
Closed -$4.83M
AAPL icon
3388
Apple
AAPL
$4.46T
-3,916,132
Closed -$249M
ABM icon
3389
ABM Industries
ABM
$2.82B
-218,000
Closed -$5.31M
ABR icon
3390
Arbor Realty Trust
ABR
$981M
-354,740
Closed -$1.74M
ACA icon
3391
Arcosa
ACA
$7.12B
-42,000
Closed -$1.67M
ACB
3392
Aurora Cannabis
ACB
$235M
-22,403
Closed -$2.4M
ACCO icon
3393
Acco Brands
ACCO
$399M
-272,447
Closed -$1.38M
ACEL icon
3394
Accel Entertainment
ACEL
$1.01B
-14,200
Closed -$107K
ACR
3395
ACRES Commercial Realty
ACR
$101M
-168,595
Closed -$1.4M
ADBE icon
3396
Adobe
ADBE
$108B
-212,333
Closed -$67.6M
ADC icon
3397
Agree Realty
ADC
$9.34B
-18,800
Closed -$1.16M
AEHR icon
3398
Aehr Test Systems
AEHR
$4.02B
-77,299
Closed -$129K
AER icon
3399
AerCap
AER
$23.5B
-57,800
Closed -$1.32M
AIG icon
3400
American International
AIG
$39.8B
-763,660
Closed -$18.5M

Similar funds

Jim Simons's Q2 2020 Portfolio in Review

As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Jim Simons opened a new position in Uber worth $187M.

  • Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
  • Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
  • Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
  • Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
  • Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
  • Jim Simons opened 584 new positions and closed 596 in Q2 2020.
  • Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.